July 16, 2026 10:44 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'He could die in two days': Delhi HC plea seeks force-feeding of Sonam Wangchuk as fast enters Day 18 | 'Tonight's defeat is hard to take': Emmanuel Macron reacts after France crash out of World Cup, congratulates Spain | Spain cruise past France to storm into FIFA World Cup 2026 final with clinical 2-0 victory | Taslima Nasrin announces Kolkata return after 20 years to attend literary event at Rabindra Sadan | 'We must not watch one of our greatest minds be sacrificed': Zeenat Aman backs Sonam Wangchuk, urges govt to open dialogue | 'I don't want Phunsukh Wangdu to die': '3 Idiots' star Omi Vaidya's emotional appeal for Sonam Wangchuk | Middle East Crisis: Iran strikes UAE tankers in Strait of Hormuz, Indian crew member killed | Picnic turns into horror: Woman allegedly harassed, family chased for 15 km in Nashik | 'Mannat is a private property': Supreme Court clears renovation of Shah Rukh Khan's Bandra residence | Bengal CM Suvendu Adhikari backs move to stop entry to Bankra Mosque inside Kolkata airport operational area
Serum Institute
PIB

Had a good interaction with team: Indian PM Narendra Modi tweets after visiting Serum Institute of India

| @indiablooms | Nov 29, 2020, at 12:38 am

Pune: Indian PM Narendra Modi on Saturday visited Pune's Serum Institute of India, which is working on the coronavirus vaccine, and interacted with the team at the Institute.

"They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing," read a government statement.

In a tweet, the Prime Minister said, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."  

The institute's CEO Adar Poonawala thannked PM and tweeted: "Thank you @narendramodi for visiting @SerumInstIndia . We share your vision and continue to work towards ensuring a safe and secure India."

The PM earlier in the day visited  Bharat Biotech International Limited (BBIL) at Genome Valley in Shamirpet and reviewed the progress on the manufacturing of indigenous COVID-19 vaccine 'Covaxin'.

In Ahmedabad, he reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.